TIMP2 and neoplasm: However, distinct variations in functional outcomes related to in vitro chemosensitivity, and in vivo tumour burden and metastatic dissemination in peritoneal organs existed between CRISPR/Cas9 edited gRNA2 and gRNA1 cells which had different levels of TIMP-2 suppression.